Apellis Pharmaceuticals Inc (APLS) — Net Asset Quality Index
Apellis Pharmaceuticals Inc (APLS) has a Net Asset Quality Index of 38.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.08 Billion minus total liabilities of $667.61 Million yields net assets of $414.92 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Apellis Pharmaceuticals Inc (APLS) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Apellis Pharmaceuticals Inc Net Asset Quality Index Over Time (2013–2025)
This chart shows how Apellis Pharmaceuticals Inc's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 38.3%, representing net assets of $414.92 Million against total assets of $1.08 Billion USD. See Apellis Pharmaceuticals Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Apellis Pharmaceuticals Inc (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Apellis Pharmaceuticals Inc from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see APLS market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.4% | $370.15 Million | $1.08 Billion | $705.11 Million | ▲ +8.6 pp |
| 2024 | 25.8% | $228.54 Million | $885.05 Million | $656.51 Million | ▲ +1.2 pp |
| 2023 | 24.7% | $194.52 Million | $788.73 Million | $594.21 Million | ▲ +2.3 pp |
| 2022 | 22.3% | $169.87 Million | $760.22 Million | $590.35 Million | ▼ -0.2 pp |
| 2021 | 22.5% | $198.66 Million | $881.76 Million | $683.10 Million | ▲ +1.2 pp |
| 2020 | 21.3% | $204.56 Million | $960.57 Million | $756.01 Million | ▲ +12.5 pp |
| 2019 | 8.8% | $34.23 Million | $389.24 Million | $355.02 Million | ▼ -70.3 pp |
| 2018 | 79.1% | $160.97 Million | $203.53 Million | $42.56 Million | ▼ -2.7 pp |
| 2017 | 81.8% | $148.94 Million | $182.13 Million | $33.19 Million | ▼ -5.0 pp |
| 2016 | 86.7% | $23.79 Million | $27.43 Million | $3.64 Million | ▼ -4.9 pp |
| 2015 | 91.6% | $34.98 Million | $38.18 Million | $3.20 Million | ▼ -0.8 pp |
| 2014 | 92.4% | $13.22 Million | $14.31 Million | $1.08 Million | ▲ +5.5 pp |
| 2013 | 87.0% | $4.52 Million | $5.20 Million | $676.96K | — |